Literature DB >> 33488292

Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.

Ricardo Muñóz-Godínez1,2, María de Lourdes Mora-García3, Benny Weiss-Steider3, Juan José Montesinos-Montesinos4, Adriana Del Carmen Aguilar-Lemarroy5, Rosario García-Rocha3, Jorge Hernández-Montes3, Christian Azucena Don-López3, Luis Roberto Ávila-Ibarra1,3, Daniela Berenice Torres-Pineda1, Gabriela Molina-Castillo3, Rommel Chacón-Salinas6,7, Luis Vallejo-Castillo6,8, Sonia Mayra Pérez-Tapia6,7,9, Alberto Monroy-García1,2,3.   

Abstract

Persistent infection with high-risk human papillomavirus (HR-HPV) is the main factor in the development of cervical cancer (CC). The presence of immunosuppressive factors plays an important role in the development of this type of cancer. To determine whether CD39 and CD73, which participate in the production of immunosuppressive adenosine (Ado), are involved in the progression of CC, we compared the concentrations and hydrolytic activity of these ectonucleotidases in platelet-free plasma (PFP) samples between patients with low-grade squamous intraepithelial lesions (LSILs) (n = 18), high-grade squamous intraepithelial lesions (HSILs) (n = 12), and CC (n = 19) and normal donors (NDs) (n = 15). The concentrations of CD39 and CD73 in PFP increased with disease progression (r = 0.5929, p < 0.001). The PFP of patients with HSILs or CC showed the highest concentrations of CD39 (2.3 and 2.2 times that of the NDs, respectively) and CD73 (1.7 and 2.68 times that of the NDs, respectively), which were associated with a high capacity to generate Ado from the hydrolysis of adenosine diphosphate (ADP) and adenosine monophosphate (AMP). The addition of POM-1 and APCP, specific inhibitors of CD39 and CD73, respectively, inhibited the ADPase and AMPase activity of PFP by more than 90%. A high level of the 90 kD isoform of CD73 was detected in the PFP of patients with HSILs or CC. Digestion with endoglycosidase H and N-glycanase generated CD73 with weights of approximately 90 kD, 85 kD, 80 kD, and 70 kD. In addition, the levels of transforming grow factor-β (TGF-β) in the PFPs of patients with LSIL, HSIL and CC positively correlated with those of CD39 (r = 0.4432, p < 0.001) and CD73 (r = 0.5786, p < 0.001). These results suggest that persistent infection by HR-HPV and the concomitant production of TGF-β promote the expression of CD39 and CD73 to favor CC progression through Ado generation.
Copyright © 2020 Ricardo Muñóz-Godínez et al.

Entities:  

Year:  2020        PMID: 33488292      PMCID: PMC7803102          DOI: 10.1155/2020/1678780

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  47 in total

Review 1.  Adenosine signaling and the immune system: When a lot could be too much.

Authors:  Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Immunol Lett       Date:  2018-04-24       Impact factor: 3.685

2.  Serum enzymes in head and neck cancer. IV: 5-nucleotidase.

Authors:  H Lal; L Kumar; G S Kohli; A Sharma; H Goel
Journal:  J Laryngol Otol       Date:  1989-02       Impact factor: 1.469

3.  Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

Authors:  Aled Clayton; Saly Al-Taei; Jason Webber; Malcolm D Mason; Zsuzsanna Tabi
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

4.  Active and inactive ecto-5'-nucleotidase variants in liver of control and dystrophic Lama2dy mice.

Authors:  Julio C Morote-García; M Salud García-Ayllón; Francisco J Campoy; Cecilio J Vidal; Encarnación Muñoz-Delgado
Journal:  Int J Biochem Cell Biol       Date:  2004-03       Impact factor: 5.085

5.  Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD.

Authors:  F Morandi; D Marimpietri; A L Horenstein; M Bolzoni; D Toscani; F Costa; B Castella; A C Faini; M Massaia; V Pistoia; N Giuliani; F Malavasi
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

6.  Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).

Authors:  Natasha T Snider; Peter J Altshuler; Shanshan Wan; Theodore H Welling; James Cavalcoli; M Bishr Omary
Journal:  Mol Biol Cell       Date:  2014-10-08       Impact factor: 4.138

7.  HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1.

Authors:  María de Lourdes Mora-García; Sofía López-Cisneros; Vianey Gutiérrez-Serrano; Rosario García-Rocha; Benny Weiss-Steider; Jorge Hernández-Montes; Héctor I Sánchez-Peña; Luis Roberto Ávila-Ibarra; Christian Azucena Don-López; Ricardo Muñóz-Godínez; Daniela Berenice Torres Pineda; Rommel Chacón-Salinas; Luis Vallejo-Castillo; Sonia Mayra Pérez-Tapia; Alberto Monroy-García
Journal:  Mediators Inflamm       Date:  2019-05-07       Impact factor: 4.711

8.  Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma.

Authors:  Karel P Alcedo; Andres Guerrero; Venkatesha Basrur; Dong Fu; Monea L Richardson; Joshua S McLane; Chih-Chiang Tsou; Alexey I Nesvizhskii; Theodore H Welling; Carlito B Lebrilla; Carol A Otey; Hong Jin Kim; M Bishr Omary; Natasha T Snider
Journal:  Hepatol Commun       Date:  2019-08-09

Review 9.  Purines, purinergic receptors, and cancer.

Authors:  Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

Review 10.  CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth.

Authors:  Bertrand Allard; Martin Turcotte; John Stagg
Journal:  J Biomed Biotechnol       Date:  2012-10-16
View more
  3 in total

1.  Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells.

Authors:  Katharina Hilgers; Sherif Abdelaziz Ibrahim; Ludwig Kiesel; Burkhard Greve; Nancy A Espinoza-Sánchez; Martin Götte
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  The relationship between soluble CD73 and the incidence of septic shock in severe sepsis patients: a cross-sectional analysis of data from a prospective FINNAKI study.

Authors:  Jun Gao; Shanglin Chen; Tianyu Kong; Deliang Wen; Qilin Yang
Journal:  Ann Transl Med       Date:  2022-03

3.  Potential roles of serum ATPase and AMPase in predicting diagnosis of colorectal cancer patients.

Authors:  Mengchen Shi; Yu Tian; Lingyuan He; Jingdan Zhang; Xiangling Yang; Huanliang Liu
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.